-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017035-mehr-final-report-2011.pdf
January 01, 2011 - Medication management was a particular focus, as
medication therapy is a significant source of medical … telehealth have significant potential to improve patient’s attention to and adherence with
disease treatment … communication did allow them to clarify issues around diet and
to continue to maintain and build their therapeutic … Office compared with ambulatory blood pressure in assessing
response to antihypertensive treatment: … Self-monitoring of blood glucose as part of a multi-
component therapy among non-insulin requiring type
-
digital.ahrq.gov/sites/default/files/docs/page/findings-and-lessons-from-improving-management-of-individuals-with-complex-health-care-needs-through-health-it-grant-initiative.pdf
February 20, 2014 - process
and then facilitate their progression through the
diagnosis and treatment process through … The
system enabled patients to give clinicians access to
information on the patient’s cancer treatment … Clinicians explain treatment alternatives to
patients, along with information on risks and ben-
efits … , and medication
therapy; the percent of patients who have access to
the personal health information … MCP researchers assess
the delivery of appropriate care for prevention, treat-
ment, and medication therapy
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015321-guise-final-report-2009.pdf
January 01, 2009 - GBS screening
Antibiotic therapy in Labor
According to this model, structure (that is … All patients known to have a positive GBS screen received antibiotic treatment in labor. … Characteristics of patients by GBS treatment
Factors
Overall
(N=1277)
GBS Treatment
No
(n … 0 $0
Risks
0.224
$32
No Risks/No Treatment
0.776 $0
Unknown GBS
0.160 $7
GBS Neg/No Treatment
0.633 … Actual treatment model: actual treatment, prior Canadian policy
Ampicillin
0.048 $9
Cefazolin
0.114
-
digital.ahrq.gov/sites/default/files/docs/publication/p20hs015426-lozzio-final-report-2005.pdf
January 01, 2005 - Department of Health and Human Services of a particular drug, device, test, treatment, or
other clinical … patient
tracking to avoid loss of cases that need services and reduce delays in delivering appropriate
treatments … Most medical institutions have found that parents are not resistant to treatment and
therapy when the … Enzyme replacement therapy is provided for a variety of metabolic conditions including
Gaucher, Fabry … Prevention of developmental disabilities through early diagnosis and treatment.
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024567-dorsch-final-report-2019.pdf
January 01, 2019 - of research will
be greater than 18 years of age, diagnosed with hypertension, and antihypertensive therapy
-
digital.ahrq.gov/sites/default/files/docs/page/Long%20Term%20Care%20e-Prescribing%20Standards%20Pilot%20Study%20-%20Final%20Report_0.pdf
August 01, 2007 - discontinued combination orders, such as medication with both routine and as needed schedules or tapered dose
therapies … coverage level from the highest coverage level to the lowest coverage level.
1.4.4.9.2 Generic and therapeutic … order entry for clinical risks such as drug/condition interaction, drug/drug interaction,
duplicate therapy … When a resident had one of two Blue Cross Blue Shield Minnesota plans administered through Prime
Therapeutics … For products with quantity limits, step therapy requirements, or similar coverage limitations,
refinements
-
digital.ahrq.gov/sites/default/files/docs/workflowtoolkit/IFQHC_operational_redesign_patient_flow_worksheet.pdf
January 01, 2007 - the patient encounter with the physician so the physician can
focus on the presenting problems and treatments … These
disease and treatment specific printouts help patients understand their illnesses, the plan of … treatment, and the proper use of medications—all aimed at making the patient an active
participant … reminders to patients (by e-mail or letter) of forthcoming appointments; needed
lab tests; and preventive therapy
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024330-ye-final-report-2018.pdf
January 01, 2018 - Studies testing various non-pharmacologic sleep promotion interventions (e.g., daytime artificial light
therapy … participants that their decision to take part in the study would in no way affect
their medical treatment … To minimize potential selection bias, the
research assistants were blinded for the treatment randomization … Then regression
models were fit where the primary predictor is group membership (treatment vs. control